Clinical trial Recruiting at 1 site Observational Ages 8 to 24

Gingivitis in kids vs young adults: comparing fluid biomarkers in the mouth

Official title: Comparison of Gingival Crevicular Fluid Biomarkers Between Childhood Gingivitis and Adolescent Gingivitis

Run by Nigde Omer Halisdemir University · NCT07607639 · Data updated 2026-11-12

This study will test whether gum fluid biomarkers differ between children and young adults with gingivitis.

More Gingivitis trials

Quick facts

Study typeObservational
Ages8 Years to 24 Years
SexAll
Enrollment80 (estimated)
SponsorNigde Omer Halisdemir University
Academic / other
Locations1 site (Niğde)
StatusRecruiting
StartedMay 22, 2026
Main results expectedOctober 2027
Study endsNovember 2027
Registry record updatedJune 10, 2026
Trial IDNCT07607639 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are systemically healthy individuals with clinically diagnosed gingivitis in the specified age ranges (8-12 or 15-24) and willingness to participate.

Probably not a fit

Participants outside the age ranges, with periodontitis, systemic diseases, recent antibiotic/anti-inflammatory use, or other exclusion criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this prospective observational study, researchers will recruit about 80 healthy participants with gingivitis, split into children (8-12) and young adults (15-24). They will measure clinical periodontal parameters and collect gingival crevicular fluid from tooth #31 to analyze IL-1β, TNF-α, IL-10, and MMP-8 using ELISA. The goal is to see age-related differences in inflammatory and anti-inflammatory biomarker profiles. Exclusions include ages 13-14, systemic diseases, recent periodontal treatment, and other factors that could confound results.

Why it matters

Potential benefit: If successful, the findings could improve understanding of age-specific inflammatory responses in gingivitis and guide future diagnostic approaches.

How similar studies have gone: Previous studies have examined GCF biomarkers in gingivitis, supporting feasibility of biomarker profiling in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Individuals aged 8-12 years (child group) or 15-24 years (young adult group)
2. Clinical diagnosis of gingivitis
3. Presence of fully erupted tooth #31 with closed apex
4. Systemically healthy individuals
5. No history of periodontal treatment in the last 3 months
6. No antibiotic or anti-inflammatory drug use in the last 3 months
7. Good cooperation and willingness to participate
8. Written informed consent from participants or legal guardians (for minors)

Exclusion Criteria:

1. Age 13-14 years (transitional pubertal period)
2. Presence of periodontitis or other periodontal diseases
3. Systemic, genetic, or immunological diseases
4. Acute oral infections or conditions requiring emergency treatment
5. Orthodontic appliances in the sampling region
6. Smokers
7. Pregnant or lactating individuals
8. Individuals with cognitive, psychological, or physical disabilities affecting cooperation
9. Inadequate eruption or incomplete root development of tooth #31
10. Refusal to participate or withdrawal of consent

Where it's running

  • Niğde Ömer Halisdemir University Faculty of Dentistry
    Niğde, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.